drug · unknown
immune globulin (human)
Phase 2updated 3mo agoby Octapharma AG🔗 ChEMBL
Phase 2community read0 votes
Unknown drug with a maximum clinical stage of Approval (across all indications), with 11 approved and 56 investigational indications.
all catalysts(0)
nothing on the calendar yet
Trials studying immune globulin (human)
- phase3Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections
- phase3Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients
- phase3A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- phase3Phase III Study To Compare The Effect of Panzyga Versus Placebo in Patients With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS/PANDAS)
- phase3Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study)
- phase3Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines in a Simulated Post-Exposure Regimen in Adults
- phase4Study to Evaluate the Efficacy and Safety of PANZYGA in Pediatric Patients With Chronic Immune Thrombocytopenia (ITP)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 4m ago
Found something off?
comments(0)
5-min edit window · permanent after that